Stay updated on PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    No additions or deletions were detected; core study details and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:48:16.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    4%
    Check dated 2025-10-05T17:39:29.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-28T11:18:53.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Released a minor version bump from v3.0.1 to v3.0.2. The 'Back to Top' link was removed as a cosmetic UI change.
    Difference
    0.2%
    Check dated 2025-09-14T00:47:38.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T21:26:08.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while also removing specific terms related to renal cell carcinoma and various types of antibodies and antineoplastic agents.
    Difference
    3%
    Check dated 2025-08-30T15:52:39.000Z thumbnail image

Stay in the know with updates to PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.